Related Experiment Video
Updated: May 22, 2026
10:35
Stereotactic Radiosurgery for Gynecologic Cancer
Published on: April 17, 2012
[Stereotactic radiotherapy for cerebral metastases using CyberKnife]
Zhurnal Voprosy Neirokhirurgii Imeni N. N. Burdenko
|May 29, 2012
Summary
Hypofractionated radiation therapy (HRST) shows advantages over radiosurgery (SRS) for large brain metastases. Both treatments offer similar disease control, but HRST demonstrates better recurrence-free survival, suggesting its biological benefits for larger tumors.
Area of Science:
- Neurosurgery
- Radiation Oncology
- Medical Physics
Context:
- Frameless stereotactic techniques have advanced radiation therapy for brain metastases.
- CyberKnife system enables treatment of large or critical brain lesions.
- Comparative analysis of hypofractionation (HRST) and radiosurgery (SRS) is crucial for optimizing treatment.
Purpose:
- To compare the effectiveness of hypofractionation (HRST) and radiosurgery (SRS) using the CyberKnife system for treating cerebral metastases.
- To evaluate overall regression, stabilization, median survival, and recurrence-free survival between HRST and SRS groups.
Summary:
- 54 patients with brain metastases were treated with CyberKnife, comparing SRS (16 patients) and HRST (8 patients).
- Overall regression and stabilization rates were comparable (81% for HRST, 79% for SRS).
- HRST showed a trend towards better median recurrence-free survival (5.5 months vs. 3.6 months for SRS).
Impact:
- Results suggest biological advantages of fractionated stereotactic radiotherapy for larger cerebral tumors compared to radiosurgery.
- Further prospective studies are needed to establish optimal dose, volume, and fractionation for stereotactic radiation treatment of brain metastases.
